5:02 pm
Dr. Reddy’s Laboratories Ltd with ticker code (RDY) have now 2 analysts in total covering the stock. The consensus rating is ‘Buy’. The target price ranges between 80.62 and 56 with a mean TP of 68.31. With the stocks previous close at 68.24 this now indicates there is a potential upside of .1%. The 50 day moving average now sits at 65.65 and the 200 day MA is 61.21. The market cap for the company is $11,242m. Find out more information at: http://www.drreddys.com
Dr. Reddy’s Laboratories Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. Dr. Reddy’s Laboratories Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment manufactures